Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes.
about
Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoproteinResveratrol and clinical trials: the crossroad from in vitro studies to human evidenceIGF-1, oxidative stress and atheroprotectionAdvances in Integrating Traditional and Omic Biomarkers When Analyzing the Effects of the Mediterranean Diet Intervention in Cardiovascular PreventionReactive Oxygen Species: A Key Hallmark of Cardiovascular DiseaseEndothelial dysfunction: a comprehensive appraisal.Ongoing clinical trials of the pleiotropic effects of statinsRole of AIF in human coronary artery endothelial cell apoptosisLOX-1 inhibition in myocardial ischemia-reperfusion injury: modulation of MMP-1 and inflammationThe Vilification of Cholesterol (for Profit?)Toxic effects of mercury on the cardiovascular and central nervous systemsInvestigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Characterization of immune cells in psoriatic adipose tissue.Low serum glutathione peroxidase activity is associated with increased cardiovascular mortality in individuals with low HDLc's.Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literatureOxidative risk for atherothrombotic cardiovascular disease.Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects.Development of capture assays for different modifications of human low-density lipoprotein.Intake of red wine in different meals modulates oxidized LDL level, oxidative and inflammatory gene expression in healthy people: a randomized crossover trial.Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease.Stretchable electrochemical impedance sensors for intravascular detection of lipid-rich lesions in New Zealand White rabbits.Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome.Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome.Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.The orientation and dynamics of estradiol and estradiol oleate in lipid membranes and HDL disc models.Association of chemerin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients.Human C-reactive protein and the metabolic syndrome.Modified low density lipoprotein and lipoprotein-containing circulating immune complexes as diagnostic and prognostic biomarkers of atherosclerosis and type 1 diabetes macrovascular disease.Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective.Atherosclerosis and inflammation.Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directionsEffect of resveratrol, tyrosol and beta-sitosterol on oxidised low-density lipoprotein-stimulated oxidative stress, arachidonic acid release and prostaglandin E2 synthesis by RAW 264.7 macrophages.Matrix metalloproteinases and atherosclerotic plaque instability.The role of matrix metalloproteinases in vascular disease.Place of pitavastatin in the statin armamentarium: promising evidence for a role in diabetes mellitus.Using oxidized low-density lipoprotein autoantibodies to predict restenosis after balloon angioplasty in patients with acute myocardial infarctionThe Dynamics of Oxidized LDL during Atherogenesis.Association between exposure to environmental tobacco smoke and biomarkers of oxidative stress among patients hospitalised with acute myocardial infarction.Potential benefits of berberine in the management of perimenopausal syndrome.Reactive oxygen species in cardiovascular disease.
P2860
Q24294419-34AD0886-D815-4CFC-9D71-49B6B2A04967Q24618313-7F560B07-411F-4E3A-823C-F64CE17D7157Q27694593-B6AD77E9-36A6-49F8-857E-A355A6C6ABD1Q28069172-EAE158D7-3AE8-4ACA-84AB-B9BFDEBD514CQ28076240-437E36E4-281E-41BF-B979-A4ABFED4C7F9Q28195411-CD8F1410-C429-4FD5-9D98-28ACF56D49F0Q28219321-E01BB772-4D35-47E9-A793-29FDAE12A68FQ28235081-FB3B8AD4-6703-4E0B-9687-BA33C921A5BDQ28583634-88403525-B79E-4572-B3EA-A609FF503578Q28603950-DF0226D6-9682-4FB5-AFBA-F4B568D8FF46Q28727224-76AD0631-7BAB-49D9-AC70-78B69F7B917AQ30245541-1255AA6E-2CA2-48BE-B7AA-25F1F8F227C2Q30592402-8D64EA53-4A50-4BB0-BFA2-F4EC0EA88CF7Q31068288-5B259B6E-BC82-4E1B-A72A-590CBF422AD0Q33536648-8D9199F5-E0FD-462E-9077-2AEFF03CA6DFQ33554184-A5EE43FE-A630-4462-AA53-E7A33122C4B3Q33576005-3F1D3241-EEEA-4BB8-BDE6-7EA5463B34CAQ33593614-C15633D5-27F4-4389-AA85-24D1CBE1224EQ33614330-B513807C-8EB8-441E-9FFD-2BDA36DC8DDAQ33642534-BF9CCAC8-C894-4ADB-B51F-D64F0A755674Q33723875-9C79C172-43F1-459D-BADB-B79C971DACA6Q33749982-7D289111-1B9B-4360-B654-51C6E9EAD0ABQ33788524-DF391514-44D3-41CF-BBB7-3A7C88B2C92AQ33822842-B2EB11B3-AF74-4FC7-8941-A4BF5E655B40Q33990957-D8539B84-7D44-4E72-9703-1C845EA315BFQ34011460-E0C0B8F5-C6BB-445A-98FF-237B79A79B74Q34066540-D1DAF264-B556-4D31-8504-2F687D98F6D9Q34072528-A0F6AE21-CF0B-4C13-9303-55B8B0199C2CQ34357562-AE6A4B9A-0275-455C-BE92-034B293B0A6CQ34514032-C5D8EA11-CF53-48C8-B828-8630C52B2974Q34518372-6C99AE0C-2259-4633-BC22-0E8C8C68BC60Q34586105-AFCD1C57-3AB2-4A6A-81CE-5CEE04843544Q34655385-E1C01385-8CF6-4D2B-9660-A33BAE29F1EDQ34981650-84792C47-8891-4E1F-B41D-A9B5A3BB1866Q34999753-68E3CDA1-85A4-4AAA-A026-DAE3D37232BEQ35008989-46164476-7060-4A43-9862-BE6FCB8A3855Q35024665-A8B98737-7CD8-401A-BDBB-C0131FDE5383Q35067444-A0056064-D29E-48C8-AD9A-02DB21A35539Q35138347-3C51A32F-77A8-4B21-A8CA-29902734B927Q35165194-6A3014FC-6D82-46B6-90D2-40B534FC3BF9
P2860
Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@en
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@nl
type
label
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@en
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@nl
prefLabel
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@en
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@nl
P2093
P1433
P1476
Elevated levels of oxidized lo ...... y of acute coronary syndromes.
@en
P2093
P304
P356
10.1161/01.CIR.103.15.1955
P407
P577
2001-04-01T00:00:00Z